Evofem Biosciences (EVFM) Preferred Stock Liabilities (2017 - 2026)
Evofem Biosciences (EVFM) posted Preferred Stock Liabilities of $5.03 million for Q2 2026, up 5.0% from $4.79 million a year earlier and up 2.2% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Preferred Stock Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Evofem Biosciences' Preferred Stock Liabilities came in at $4.9 million, up 2.4% from FY2024.
- Annual Preferred Stock Liabilities shows a four-year compound annual growth rate of 0.8% (FY2021 to FY2025).
- In prior years, Evofem Biosciences' Preferred Stock Liabilities was $4.78 million in FY2024 (+4.1%), $4.59 million in FY2023 and $4.74 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Preferred Stock Liabilities since Q4 2017.
- On a year-over-year basis, Preferred Stock Liabilities has increased in each of the last eight quarters, with growth averaging 23.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Preferred Stock Liabilities ranged from 2.1% (Q2 2025) to 164.4% (Q3 2024).
- According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $4.92 million (Q1 2026), $4.9 million (Q4 2025) and $4.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | 5.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.03 Mn |
| Mar 31, 2026 | 4.92 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Sep 30, 2025 | 4.90 Mn |
| Jun 30, 2025 | 4.79 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 4.78 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 4.69 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Mar 31, 2022 | 2.52 Mn |
| Dec 31, 2021 | 4.74 Mn |
| Dec 31, 2017 | 189.87 Mn |
API Access
Evofem Biosciences Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();